PREhabilitation of Candidates for REnal Transplantation (PreCareTx)
Primary Purpose
Prehabilitation, Kidney Transplant Candidates, Frailty
Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Exercise
Sponsored by
About this trial
This is an interventional treatment trial for Prehabilitation
Eligibility Criteria
Inclusion Criteria:
- Adult kidney transplant candidates (≥18 years)
- Listed for kidney transplantation on the UMCG kidney transplant waiting list at the start of the study or wait listed during the inclusion period (October 2022 - March 2025).
Exclusion Criteria:
- Inability to read and/or speak Dutch
- Combined organ transplantation (e.g., kidney+pancreas, kidney+liver)
- In case of living donor kidney transplant: a transplantation planned within 3 months
- Involved in a lifestyle intervention program
Sites / Locations
- University Medical Center GroningenRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
prehabilitation group
control group
Arm Description
care as usual and pre habilitation intervention
care as usual
Outcomes
Primary Outcome Measures
Change in frailty status
Frailty will be measured with the Tilburg Frailty Index, which measures the physical, psychological and social domain of frailty with 15 items. The total score ranges from 0-15, in which higher a score indicates a higher level of frailty
Change in frailty status
Frailty will be measured with the Tilburg Frailty Index, which measures the physical, psychological and social domain of frailty with 15 items. The total score ranges from 0-15, in which higher a score indicates a higher level of frailty
Secondary Outcome Measures
Change in functional capacity
The Duke Activity Status Index (DASI) will be used to measure functional capacity. The DASI consists of 12 items regarding different aspects of functioning which are answered dichotomously (yes/no). Based on the results, a total DASI score (range 0-58.2) can be calculated. A score ≤34 is indicative of low functional capacity.
Change in functional capacity
The Duke Activity Status Index (DASI) will be used to measure functional capacity. The DASI consists of 12 items regarding different aspects of functioning which are answered dichotomously (yes/no). Based on the results, a total DASI score (range 0-58.2) can be calculated. A score ≤34 is indicative of low functional capacity.
Change in handgrip strength
Hand grip strength will be assessed using the Jamar Hydraulic Hand Dynamometer (Patterson Medical JAMAR 5030J1, Warrenville, Canada). Hand grip strength will be tested three times with 30 seconds of rest in between each attempt. The dominant hand will be noted in all measurements.
Change in handgrip strength
Hand grip strength will be assessed using the Jamar Hydraulic Hand Dynamometer (Patterson Medical JAMAR 5030J1, Warrenville, Canada). Hand grip strength will be tested three times with 30 seconds of rest in between each attempt. The dominant hand will be noted in all measurements.
Change in Fat Free Mass
Regarding nutritional status change in fat free mass will be the main outcomes measure. Bio-impedance analysis will be performed to assess body composition. A lower percentage of fat free mass is indicative of a better nutritional status.
Change in Fat Free Mass
Regarding nutritional status change in fat free mass will be the main outcomes measure. Bio-impedance analysis will be performed to assess body composition. A lower percentage of fat free mass is indicative of a better nutritional status.
Change in Body Mass Index
Body mass index will be calculated as follows: weight (in kg) divided by height (m) squared (kg/m2). A score < 20 is indicative of underweight, a score > 30 is indicative of overweight.
Change in Body Mass Index
Body mass index will be calculated as follows: weight (in kg) divided by height (m) squared (kg/m2). A score < 20 is indicative of underweight, a score > 30 is indicative of overweight.
Change in symptoms of fatigue
fatigue will be measured one subscale of the Checklist Individual Strength; subjective fatigue. This subscale consists of 8 statements concerning feelings of fatigue that can be answered on a 7-point Likert scale (1 = yes, totally agree - 7 = no, totally disagree) A score of ≥27 is indicative of abnormal fatigue.
Change in symptoms of fatigue
fatigue will be measured one subscale of the Checklist Individual Strength; subjective fatigue. This subscale consists of 8 statements concerning feelings of fatigue that can be answered on a 7-point Likert scale (1 = yes, totally agree - 7 = no, totally disagree) A score of ≥27 is indicative of abnormal fatigue.
Change in symptoms of anxiety
Symptoms of anxiety will be measured using the short-form of the State-Trait Anxiety Inventory consisting of 6 items rated on a 4-point intensity scale (1 = not at all; 4 = very much), resulting in a total sum score between 6 and 24. Higher scores indicate more symptoms of anxiety. A cut-off score of ≥12 is used to identify clinically relevant cases.
Change in symptoms of anxiety
Symptoms of anxiety will be measured using the short-form of the State-Trait Anxiety Inventory consisting of 6 items rated on a 4-point intensity scale (1 = not at all; 4 = very much), resulting in a total sum score between 6 and 24. Higher scores indicate more symptoms of anxiety. A cut-off score of ≥12 is used to identify clinically relevant cases.
Change in symptoms of depression
Symptoms of depression will be measured using the Patient Health Questionnaire-9, a self-report questionnaire used to screen for severity of depressive symptoms, consisting of nine items and are answered on a four-point Likert scale (0 = not at all, 3 = almost every day). A total score (0-27) is calculated by adding up all scores. A score of >9 is indicative of clinically relevant symptoms of depression.
Change in symptoms of depression
Symptoms of depression will be measured using the Patient Health Questionnaire-9, a self-report questionnaire used to screen for severity of depressive symptoms, consisting of nine items and are answered on a four-point Likert scale (0 = not at all, 3 = almost every day). A total score (0-27) is calculated by adding up all scores. A score of >9 is indicative of clinically relevant symptoms of depression.
Change in Health related Quality of Life
To assess Health-related Quality of life (HRQoL), the Short Form-36 (SF-36) health survey will be used. It is a 36-item, self-reported questionnaire that captures participants' perceptions of their own health and wellbeing. Based on the item scores, a physical component score (PCS) and a mental component score (MCS) will be calculated. The PCS consists of items related to general health, physical health, and role limitations due to impairment of physical health and pain. The MCS consists of items related to emotional well-being, and role limitations due to emotional problems, impaired social functioning, and impaired vitality. A higher score indicates a better perceived HRQoL
Change in Health related Quality of Life
To assess Health-related Quality of life (HRQoL), the Short Form-36 (SF-36) health survey will be used. It is a 36-item, self-reported questionnaire that captures participants' perceptions of their own health and wellbeing. Based on the item scores, a physical component score (PCS) and a mental component score (MCS) will be calculated. The PCS consists of items related to general health, physical health, and role limitations due to impairment of physical health and pain. The MCS consists of items related to emotional well-being, and role limitations due to emotional problems, impaired social functioning, and impaired vitality. A higher score indicates a better perceived HRQoL
Full Information
NCT ID
NCT05489432
First Posted
July 28, 2022
Last Updated
March 31, 2023
Sponsor
University Medical Center Groningen
1. Study Identification
Unique Protocol Identification Number
NCT05489432
Brief Title
PREhabilitation of Candidates for REnal Transplantation
Acronym
PreCareTx
Official Title
PREhabilitation of CAndidates for REnal Transplantation: A Hybrid Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 23, 2023 (Actual)
Primary Completion Date
October 2025 (Anticipated)
Study Completion Date
October 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Medical Center Groningen
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In this study a personalized, multi modal prehabilitation intervention will be offered to n = 64 patients on the kidney transplant waiting-list. The control group (n = 64) will receive care as usual. Based on a screening, comprised of questionnaires and physical test, eligible kidney transplant candidates who have modifiable problems on the domains of physical capacity, nutritional status or psychological well-being, will be randomly assigned to either the intervention or control group. The intervention will consist of a 12-week prehabilitation program followed by a 12 week consolidation program. Primary outcome will be frailty status as an indicator of overall health status and will be measured at screening (T0), 13 weeks (T1) and 26 weeks (T2)
Detailed Description
Rationale: The health status of kidney transplant candidates (KTCs) is often compromised due to their chronic kidney disease, comorbidities and/or dialysis. To be able to handle the stress of the upcoming transplant surgery and enhance post-operative recovery, it is important for KTCs to be in an optimal physical and psychological condition. Prehabilitation, the enhancement of a person's functional capacity in order to improve the ability to withstand a future stressor, may be an effective intervention to improve the overall health status of KTCs. Although research investigating prehabilitation in transplant populations is limited, studies showed that prehabilitation during the waiting-list period is safe and feasible, and may have a positive effect on pre- and postoperative outcomes. We hypothesized that, compared to usual care, a prehabilitation program tailored to individual patients' needs will improve the overall health status of KTCs.
Objective: To examine the effect of a multi-modal prehabilitation program on frailty and other indicators of physical and psychological fitness of KTCs during the waiting-list period and its optimal implementation in a real-world situation.
Study design: An effectiveness-implementation hybrid type 1 study design comprised of a randomized controlled trial to test the effectiveness of prehabilitation to improve the overall health status of KTCs, and a mixed-methods study to gather information on its potential for further implementation.
Study population: Adult patients, who are currently on the University Medical Center Groningen kidney transplant waiting-list or will be wait listed during the study period.
Intervention: A twelve-week prehabilitation program consisting of physical exercises, nutritional measures and psychosocial interventions based on the KTCs personal needs as indicated by an assessment consisting of questionnaires and physical tests. The prehabilitation program will be followed by a twelve-week consolidation program, in which the intensity and frequency of the interventions will be lower, in order to enhance the incorporation of the interventions into the daily life of the KTC. During the intervention period, participants will receive counseling by a lifestyle coach.
Main study parameters/endpoints: Frailty will serve as a proxy for overall health status. Therefore, the primary endpoint of this study is change in frailty status as measured by the Tilburg Frailty Indicator. Secondary endpoints include changes in physical fitness, nutritional status, psychological well-being and quality of life. Endpoints will be measured at T0 (baseline assessment), T1 (13 weeks after T0) and T2 (26 weeks after T0).
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The burden for all participants (intervention and control group) will consist of filling out questionnaires (T0, 60 minutes), T1 (30 minutes) and T2 (30 minutes), completing at all three measurement points a food diary (45 minutes per measurement), to wear an activity tracker for three days, and three study visits at the UMCG in which physical tests will be performed (50-60 minutes per measurement). In total this will take ≈7 hours of their time during the 26 weeks of the study. In addition, participants in the intervention group will be asked to exercise ≈30 minutes a day and will have a weekly 10-to-15-minute counselling session by (video)call with the lifestyle coach. Efforts will differ per patient as the prehabilitation program will be tailor-made. Although the risk that patients may get injured during exercise is negligible, this will be monitored weekly by the lifestyle coach. We believe it is justified to perform the proposed study given the scarcity of data on the effectiveness of prehabilitation in KTCs and the potential of major improvements in physical functioning and psychological well-being and transplantation outcomes in this vulnerable patient group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prehabilitation, Kidney Transplant Candidates, Frailty
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
An effectiveness-implementation hybrid type 1 study design comprised of a randomized controlled trial to test the effectiveness of prehabilitation to improve the overall health status of KTCs, and a mixed-methods study to gather information on its potential for further implementation.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
128 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
prehabilitation group
Arm Type
Experimental
Arm Description
care as usual and pre habilitation intervention
Arm Title
control group
Arm Type
No Intervention
Arm Description
care as usual
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Other Intervention Name(s)
nutritional measures, stress reduction
Intervention Description
A twelve-week prehabilitation program consisting of physical exercises, nutritional measures and psychosocial interventions based on the KTCs personal needs as indicated by an assessment consisting of questionnaires and physical tests. The prehabilitation program will be followed by a twelve-week consolidation program, in which the intensity and frequency of the interventions will be lower, in order to enhance the incorporation of the interventions into the daily life of the KTC. During the intervention period, participants will receive counseling by a lifestyle coach.
Primary Outcome Measure Information:
Title
Change in frailty status
Description
Frailty will be measured with the Tilburg Frailty Index, which measures the physical, psychological and social domain of frailty with 15 items. The total score ranges from 0-15, in which higher a score indicates a higher level of frailty
Time Frame
Baseline-week 13
Title
Change in frailty status
Description
Frailty will be measured with the Tilburg Frailty Index, which measures the physical, psychological and social domain of frailty with 15 items. The total score ranges from 0-15, in which higher a score indicates a higher level of frailty
Time Frame
week 13- week 26
Secondary Outcome Measure Information:
Title
Change in functional capacity
Description
The Duke Activity Status Index (DASI) will be used to measure functional capacity. The DASI consists of 12 items regarding different aspects of functioning which are answered dichotomously (yes/no). Based on the results, a total DASI score (range 0-58.2) can be calculated. A score ≤34 is indicative of low functional capacity.
Time Frame
Baseline-week 13
Title
Change in functional capacity
Description
The Duke Activity Status Index (DASI) will be used to measure functional capacity. The DASI consists of 12 items regarding different aspects of functioning which are answered dichotomously (yes/no). Based on the results, a total DASI score (range 0-58.2) can be calculated. A score ≤34 is indicative of low functional capacity.
Time Frame
week 13- week 26
Title
Change in handgrip strength
Description
Hand grip strength will be assessed using the Jamar Hydraulic Hand Dynamometer (Patterson Medical JAMAR 5030J1, Warrenville, Canada). Hand grip strength will be tested three times with 30 seconds of rest in between each attempt. The dominant hand will be noted in all measurements.
Time Frame
Baseline-week 13
Title
Change in handgrip strength
Description
Hand grip strength will be assessed using the Jamar Hydraulic Hand Dynamometer (Patterson Medical JAMAR 5030J1, Warrenville, Canada). Hand grip strength will be tested three times with 30 seconds of rest in between each attempt. The dominant hand will be noted in all measurements.
Time Frame
week 13- week 26
Title
Change in Fat Free Mass
Description
Regarding nutritional status change in fat free mass will be the main outcomes measure. Bio-impedance analysis will be performed to assess body composition. A lower percentage of fat free mass is indicative of a better nutritional status.
Time Frame
Baseline-week 13
Title
Change in Fat Free Mass
Description
Regarding nutritional status change in fat free mass will be the main outcomes measure. Bio-impedance analysis will be performed to assess body composition. A lower percentage of fat free mass is indicative of a better nutritional status.
Time Frame
week 13- week 26
Title
Change in Body Mass Index
Description
Body mass index will be calculated as follows: weight (in kg) divided by height (m) squared (kg/m2). A score < 20 is indicative of underweight, a score > 30 is indicative of overweight.
Time Frame
Baseline-week 13
Title
Change in Body Mass Index
Description
Body mass index will be calculated as follows: weight (in kg) divided by height (m) squared (kg/m2). A score < 20 is indicative of underweight, a score > 30 is indicative of overweight.
Time Frame
week 13- week 26
Title
Change in symptoms of fatigue
Description
fatigue will be measured one subscale of the Checklist Individual Strength; subjective fatigue. This subscale consists of 8 statements concerning feelings of fatigue that can be answered on a 7-point Likert scale (1 = yes, totally agree - 7 = no, totally disagree) A score of ≥27 is indicative of abnormal fatigue.
Time Frame
Baseline-week 13
Title
Change in symptoms of fatigue
Description
fatigue will be measured one subscale of the Checklist Individual Strength; subjective fatigue. This subscale consists of 8 statements concerning feelings of fatigue that can be answered on a 7-point Likert scale (1 = yes, totally agree - 7 = no, totally disagree) A score of ≥27 is indicative of abnormal fatigue.
Time Frame
week 13- week 26
Title
Change in symptoms of anxiety
Description
Symptoms of anxiety will be measured using the short-form of the State-Trait Anxiety Inventory consisting of 6 items rated on a 4-point intensity scale (1 = not at all; 4 = very much), resulting in a total sum score between 6 and 24. Higher scores indicate more symptoms of anxiety. A cut-off score of ≥12 is used to identify clinically relevant cases.
Time Frame
Baseline-week 13
Title
Change in symptoms of anxiety
Description
Symptoms of anxiety will be measured using the short-form of the State-Trait Anxiety Inventory consisting of 6 items rated on a 4-point intensity scale (1 = not at all; 4 = very much), resulting in a total sum score between 6 and 24. Higher scores indicate more symptoms of anxiety. A cut-off score of ≥12 is used to identify clinically relevant cases.
Time Frame
week 13- week 26
Title
Change in symptoms of depression
Description
Symptoms of depression will be measured using the Patient Health Questionnaire-9, a self-report questionnaire used to screen for severity of depressive symptoms, consisting of nine items and are answered on a four-point Likert scale (0 = not at all, 3 = almost every day). A total score (0-27) is calculated by adding up all scores. A score of >9 is indicative of clinically relevant symptoms of depression.
Time Frame
Baseline-week 13
Title
Change in symptoms of depression
Description
Symptoms of depression will be measured using the Patient Health Questionnaire-9, a self-report questionnaire used to screen for severity of depressive symptoms, consisting of nine items and are answered on a four-point Likert scale (0 = not at all, 3 = almost every day). A total score (0-27) is calculated by adding up all scores. A score of >9 is indicative of clinically relevant symptoms of depression.
Time Frame
week 13- week 26
Title
Change in Health related Quality of Life
Description
To assess Health-related Quality of life (HRQoL), the Short Form-36 (SF-36) health survey will be used. It is a 36-item, self-reported questionnaire that captures participants' perceptions of their own health and wellbeing. Based on the item scores, a physical component score (PCS) and a mental component score (MCS) will be calculated. The PCS consists of items related to general health, physical health, and role limitations due to impairment of physical health and pain. The MCS consists of items related to emotional well-being, and role limitations due to emotional problems, impaired social functioning, and impaired vitality. A higher score indicates a better perceived HRQoL
Time Frame
Baseline-week 13
Title
Change in Health related Quality of Life
Description
To assess Health-related Quality of life (HRQoL), the Short Form-36 (SF-36) health survey will be used. It is a 36-item, self-reported questionnaire that captures participants' perceptions of their own health and wellbeing. Based on the item scores, a physical component score (PCS) and a mental component score (MCS) will be calculated. The PCS consists of items related to general health, physical health, and role limitations due to impairment of physical health and pain. The MCS consists of items related to emotional well-being, and role limitations due to emotional problems, impaired social functioning, and impaired vitality. A higher score indicates a better perceived HRQoL
Time Frame
week 13- week 26
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult kidney transplant candidates (≥18 years)
Listed for kidney transplantation on the UMCG kidney transplant waiting list at the start of the study or wait listed during the inclusion period (October 2022 - March 2025).
Exclusion Criteria:
Inability to read and/or speak Dutch
Combined organ transplantation (e.g., kidney+pancreas, kidney+liver)
In case of living donor kidney transplant: a transplantation planned within 3 months
Involved in a lifestyle intervention program
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Coby C Annema, PhD
Phone
+31621551352
Email
j.h.annema@umcg.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Avril Haanstra, MsC
Phone
+31503611490
Email
a.j.haanstra@umcg.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Coby Annema, PhD
Organizational Affiliation
University Medical Center Groningen
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Medical Center Groningen
City
Groningen
ZIP/Postal Code
9700 RB
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Coby Annema, PhD
Phone
+31503611490
Email
j.h.annema@umcg.nl
First Name & Middle Initial & Last Name & Degree
Avril Haanstra, MSc
Phone
+31625651034
Email
a.j.haanstra@umcg.nl
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
PREhabilitation of Candidates for REnal Transplantation
We'll reach out to this number within 24 hrs